Skip to content

Pilot-testing of the Japanese version of EORTC QLQ-FA13

Pilot-testing of the Japanese version of EORTC QLQ-FA13 - Pilot-testing of the Japanese version of EORTC QLQ-FA13

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013462
Enrollment
15
Registered
2014-03-20
Start date
2014-03-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

None listed

Sponsors

Tohoku University Graduate School of Medicine, Division of Biostatistics
Lead Sponsor
Tokyo Medical University Hospital Keiyu Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Any cancer diagnosis 2.Native Japanese speaker

Exclusion criteria

Exclusion criteria: 1. Severe psychiatric disorder 2. Linguistic difficulty preventing patients from completing the questionnaires.

Design outcomes

Primary

MeasureTime frame
The primary outcomes associated with this study include the ability for the EORTC QLQ-FA13 to be used in Japan with confidence that the Japanese items are translated correctly and are culturally meaningful and appropriate.

Countries

Japan

Contacts

Public ContactTakashi Kawaguchi

Tokyo University of Pharmacy and Life Sciences Department of Practical Pharmacy

tkawa@toyaku.ac.jp042-676-1521

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026